106 related articles for article (PubMed ID: 5356119)
1. [Use of epsilon aminocaproic acid in abnormal hemorrhage using intrauterine contraceptive devices].
Rueda González R
Rev Colomb Obstet Ginecol; 1969; 20(4):273-8. PubMed ID: 5356119
[TBL] [Abstract][Full Text] [Related]
2. [Calcium lonazolac and blood loss in users of intrauterine devices. Preliminary report].
Rubio Lotvin B; Ruíz Moreno JA; González Ansorena R; Ibarrola E; Uranga G; Benítez E
Ginecol Obstet Mex; 1986 Aug; 54():221-4. PubMed ID: 3781294
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
4. [Results of bleeding prevention with fibrinolysis inhibitors in intrauterine contraception].
Tauber PF; Werling E; Klöppel A; Ludwig H
Arch Gynecol; 1979 Jul; 228(1-4):637-8. PubMed ID: 485529
[No Abstract] [Full Text] [Related]
5. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
Ozalp S; Kabukcuoglu S; Tanir HM
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
[TBL] [Abstract][Full Text] [Related]
6. Aminocaproic acid for bleeding associated with intrauterine devices?
Drug Ther Bull; 1972 Sep; 10(20):78-80. PubMed ID: 4664710
[No Abstract] [Full Text] [Related]
7. [Uterine hemorrhage during intrauterine contraception. Pathophysiology and therapy].
Tauber PF
Med Welt; 1979 Oct; 30(42):1547-53. PubMed ID: 93677
[No Abstract] [Full Text] [Related]
8. Management of uterine bleeding by PGs or their synthesis inhibitors.
Toppozada M; El-Attar A; El-Ayyat MA; Khamis Y
Adv Prostaglandin Thromboxane Res; 1980; 8():1459-63. PubMed ID: 6769315
[TBL] [Abstract][Full Text] [Related]
9. IUD use and unexplained vaginal bleeding.
Huggins GR
Obstet Gynecol; 1981 Oct; 58(4):409-16. PubMed ID: 7279336
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device.
Kulkarni S; Wynter HH; Desai P
West Indian Med J; 1993 Sep; 42(3):124-5. PubMed ID: 8273322
[TBL] [Abstract][Full Text] [Related]
11. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
12. [IUD insertion during cesarean section and its most frequent complications].
Alvarez Pelayo J; Borbolla Sala ME
Ginecol Obstet Mex; 1994 Nov; 62():330-5. PubMed ID: 7821830
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of haemorrhage during insertion of IUD].
Nesit V; Valenta M
Cesk Gynekol; 1975 Mar; 40(2):137-9. PubMed ID: 1131935
[TBL] [Abstract][Full Text] [Related]
14. [A new intrauterine device].
Ingemanson CA
Lakartidningen; 1971 Dec; 68(51):5928-30. PubMed ID: 5139545
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
16. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
17. Three years experience with copper T-200.
Kanitkar SD; Tare VS; Tambay PY; Mutatkar KR
J Indian Med Assoc; 1983 May; 80(9-10):148-9. PubMed ID: 6644055
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
Dasgupta PR; Dutta S; Banerjee P; Majumdar S
Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of uterine hemorrhage in obstetrics with epsilon-aminocaproic acid].
Shilko NA; Borsuk GT; Gurova IF; Zhurbenko IuK; Matsiuk AG; Franchuk AE; Iushchishina SV
Vopr Okhr Materin Det; 1968 Sep; 13(9):63-7. PubMed ID: 5304942
[No Abstract] [Full Text] [Related]
20. Uterine response to PGE2 with IUDs: a possible mechanism of action and side effect.
Toppozada M; Rizk M; Thabet MH; Shaala S
Contracept Deliv Syst; 1980 Oct; 1(4):349-63. PubMed ID: 12262137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
